INBX vs BIIB: Which Stock is Better?
Side-by-side comparison of Inhibrx Biosciences Inc and Biogen Inc in 2026
INBX
Inhibrx Biosciences Inc
$88.23
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | INBX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $1.21B | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | -1.0% | -0.1% | BIIB |
| Gross Margin | -8594.5% | 78.9% | BIIB |
Analyze INBX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INBX or BIIB a better investment?
Comparing INBX and BIIB: Inhibrx Biosciences Inc has a market cap of $1.21B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INBX and BIIB?
INBX (Inhibrx Biosciences Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INBX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INBX or BIIB?
BIIB has higher revenue growth at -0.1% vs -1.0% for INBX.
Which company is more profitable: INBX or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -8594.5% for INBX.
Which is the larger company: INBX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $1.21B for INBX.
Should I buy INBX or BIIB in 2026?
Both INBX and BIIB have investment merit. INBX trades at $88.23 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INBX and BIIB stock?
Key differences: Market Cap ($1.21B vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (-1.0% vs -0.1%), Gross Margin (-8594.5% vs 78.9%).